Cambridge-headquartered Dante Labs is a global genomic platform for diagnostics and therapeutics, focused on integrating genomic sequencing and medical data to provide clinical solutions.

This week, the company acquired Cambridge Cancer Genomics (, a leader in machine learning for clinical oncology. It now aims to create a single software platform enabling patient-centric precision oncology at scale for cancer patients. The platform, integrating’s OncOS machine learning oncology software with Dante Labs’ Immensa Genomics Interpretation Software, would combine medical, germline, somatic and liquid biopsy data analysis.

The OncOS software enables data-driven precision oncology and the systematic development of data-driven biomarkers indicative of treatment response. Dante Labs’ Immensa software generates personalised reports for pharmacogenomics, rare diseases, predisposition to common diseases and nutrigenomics, integrating guidelines from the American College of Medical Genetics.

CEO and cofounder of Dr John Cassidy commented: “Matching cancer patients to the best therapy has been a longstanding problem in the field of oncology. was founded on the premise that every patient should be on the right treatment, at the right time, to beat their cancer.

“Since that founding moment, the team has dedicated themselves to state-of-the-art software development and fundamental research in tumour evolution, treatment response and AI, to enable better deployment of targeted therapies for all. Now, with Dante Labs’ commercial reach and expertise in direct-to-consumer genomic testing, our products will be even closer to where they can make the ultimate impact – in the lives of patients.”

The precision oncology market is currently valued at around $58,450m, and set to reach $98,550m by 2026. Dante Labs says the project it is pursuing with’s software will address an estimated $75bn market opportunity.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.